Literature DB >> 18320182

Tizanidine-induced hypotension in patients with liver cirrhosis.

Kenji Momo, Masato Homma, Makoto Abei, Ichinosuke Hyodo, Yukinao Kohda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320182     DOI: 10.1007/s00228-008-0469-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.

Authors:  Xiaoping Chen; Liqing Wang; Lianteng Zhi; Gangqiao Zhou; Haijian Wang; Xiumei Zhang; Bingtao Hao; Yunping Zhu; Zeneng Cheng; Fuchu He
Journal:  Clin Pharmacol Ther       Date:  2005-09       Impact factor: 6.875

2.  Drug interaction of tizanidine and fluvoxamine.

Authors:  Kenji Momo; Kosuke Doki; Hiroyuki Hosono; Masato Homma; Yukinao Kohda
Journal:  Clin Pharmacol Ther       Date:  2004-11       Impact factor: 6.875

3.  Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry.

Authors:  Ramakrishna V S Nirogi; Vishwottam N Kandikere; Manoj Shukla; Koteshwara Mudigonda; Santosh Maurya
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

4.  Drug interaction of tizanidine and ciprofloxacin: case report.

Authors:  Kenji Momo; Masato Homma; Yukinao Kohda; Norio Ohkoshi; Toshihiro Yoshizawa; Akira Tamaoka
Journal:  Clin Pharmacol Ther       Date:  2006-12       Impact factor: 6.875

5.  Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.

Authors:  Marika T Granfors; Janne T Backman; Mikko Neuvonen; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2004-12       Impact factor: 6.875

6.  A peek at the Child-Turcotte classification.

Authors:  H O Conn
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

7.  Liver disease selectively modulates cytochrome P450--mediated metabolism.

Authors:  Reginald F Frye; Nathalie K Zgheib; Gary R Matzke; Diego Chaves-Gnecco; Mordechai Rabinovitz; Obaid S Shaikh; Robert A Branch
Journal:  Clin Pharmacol Ther       Date:  2006-09       Impact factor: 6.875

8.  Mechanisms of tizanidine action on spasticity.

Authors:  I Milanov; D Georgiev
Journal:  Acta Neurol Scand       Date:  1994-04       Impact factor: 3.209

9.  Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro.

Authors:  Marika T Granfors; Janne T Backman; Jouko Laitila; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

10.  Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.

Authors:  Marika T Granfors; Janne T Backman; Mikko Neuvonen; Jouni Ahonen; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2004-04       Impact factor: 6.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.